Clinical trial for Chronic Kidney Disease
Official title Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients
ClinicalTrials.gov ID: NCT07657286
What this study is testing
- What it's testing
- The study wants to find out whether a 12‑week lifestyle adjustment can change inflammatory cytokines and oxidative‑stress markers in people with type 2 diabetes and moderate CKD.
- Who it's for
- Overweight adults who have type 2 diabetes and moderate chronic kidney disease.
- What's involved
- Participants will follow a prescribed lifestyle program for 12 weeks and have blood draws to measure inflammation and oxidative‑stress markers, plus routine study visits.
- Time commitment
- The trial lasts about 12 weeks and includes regular study visits for assessments and blood tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 36 to 58
You may be able to join if
- sedentary lifestyle for at least three months prior to enrollment
- body mass index (BMI) of 30-35 kg/m².
You likely can't join if
- using tobacco
- heart failure
- coronary arteries
- severe heart valve problems
- pregnant
- liver inflammation
See the full eligibility criteria
- sedentary lifestyle for at least three months prior to enrollment
- body mass index (BMI) of 30-35 kg/m².
- using tobacco
- heart failure
- coronary arteries
- severe heart valve problems
- pregnant
- liver inflammation
- kidney transplant
- physical injuries restricting them from exercising
- utilization of anti-inflammatory medications
The study team makes the final eligibility decision.
Where it is enrolling
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 36 years to 58 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cairo, Egypt. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.